(Sharecast News) - Ixico announced on Monday that it has secured a new £3.5m contract to provide imaging services for a global phase three clinical trial in Huntington's disease, marking a significant commercial win for the neuroscience-focused biomarker analytics group.
The AIM-traded company said the agreement, signed with an unnamed global...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE